Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Daily Top 10 COVID-19 publications

Deutsch | English | Español | Français | Italiano | Português; | Tiếng Việt | Türkçe


  Bacterial Infections and Mycoses

  Free Subscription


Articles published in Am J Respir Crit Care Med

Retrieve available abstracts of 74 articles:
HTML format



Single Articles


    June 2020

  1. Erratum: Tuberculosis Diagnosis in Children Using Xpert Ultra on Different Respiratory Specimens.
    Am J Respir Crit Care Med. 2020;201:1454.
    PubMed    


    May 2020
  2. SCHEUERMANN L, Pei G, Domaszewska T, Zyla J, et al
    Platelets Restrict the Oxidative Burst in Phagocytes and Facilitate Primary Progressive Tuberculosis.
    Am J Respir Crit Care Med. 2020 May 18. doi: 10.1164/rccm.201910-2063.
    PubMed     Abstract available


  3. HIBMA JE, Radtke KK, Dorman SE, Jindani A, et al
    Rifapentine Population Pharmacokinetics and Dosing Recommendations for Latent Tuberculosis Infection.
    Am J Respir Crit Care Med. 2020 May 15. doi: 10.1164/rccm.201912-2489.
    PubMed     Abstract available


  4. NYGA R, Maizel J, Nseir S, Chouaki T, et al
    Invasive Tracheobronchial Aspergillosis in Critically Ill Patients with Severe Influenza.
    Am J Respir Crit Care Med. 2020 May 14. doi: 10.1164/rccm.201910-1931.
    PubMed     Abstract available


  5. VAN ARKEL ALE, Rijpstra TA, Belderbos HNA, van Wijngaarden P, et al
    COVID-19 Associated Pulmonary Aspergillosis.
    Am J Respir Crit Care Med. 2020 May 12. doi: 10.1164/rccm.202004-1038.
    PubMed    


    April 2020
  6. STOUT JE, Turner NA, Belknap RW, Horsburgh CR, et al
    Reply to: Trials of Tuberculosis Preventive Therapy in People with HIV Infection.
    Am J Respir Crit Care Med. 2020 Apr 13. doi: 10.1164/rccm.202003-0855.
    PubMed    


  7. SWINDELLS S, Hughes M, Chaisson RE
    Trials of Tuberculosis Preventive Therapy in People with HIV Infection.
    Am J Respir Crit Care Med. 2020 Apr 13. doi: 10.1164/rccm.202003-0761.
    PubMed    


    March 2020
  8. DOOLEY KE, Miyahara S, von Groote-Bidlingmaier F, Sun X, et al
    Reply to: High-dose First-line Treatment Regimen for Recurrent Rifampicin-susceptible Tuberculosis.
    Am J Respir Crit Care Med. 2020 Mar 4. doi: 10.1164/rccm.202002-0359.
    PubMed    


  9. DECROO T, de Jong BC, Piubello A, Souleymane MB, et al
    High-dose First-line Treatment Regimen for Recurrent Rifampicin-susceptible Tuberculosis.
    Am J Respir Crit Care Med. 2020 Mar 4. doi: 10.1164/rccm.202001-0201.
    PubMed    


    February 2020
  10. KENG LT, Lee CF
    Ultrasound-Guided Transthoracic Needle Aspiration to Diagnose Invasive Pulmonary Aspergillosis.
    Am J Respir Crit Care Med. 2020 Feb 20. doi: 10.1164/rccm.202001-0008.
    PubMed    


  11. WASSERMAN S, Furin J
    Clarity with INHindsight: High-Dose Isoniazid for Drug-Resistant Tuberculosis with inhA Mutations.
    Am J Respir Crit Care Med. 2020 Feb 20. doi: 10.1164/rccm.202002-0264.
    PubMed    



  12. Erratum: Treatment of Drug-Resistant Tuberculosis. An Official ATS/CDC/ERS/IDSA Clinical Practice Guideline.
    Am J Respir Crit Care Med. 2020;201:500-501.
    PubMed    


  13. VERNON A, Bishai W
    Modeling Treatment of Latent Tuberculosis: Shortening the Leap of Faith?
    Am J Respir Crit Care Med. 2020;201:405-406.
    PubMed    


  14. ANDRES S, Merker M, Heyckendorf J, Kalsdorf B, et al
    Bedaquiline-resistant Tuberculosis: Dark Clouds on the Horizon.
    Am J Respir Crit Care Med. 2020 Feb 13. doi: 10.1164/rccm.201909-1819.
    PubMed    


    January 2020
  15. DE JAGER VR, Vanker N, van der Merwe L, van Brakel E, et al
    Optimising beta-lactams Against Tuberculosis.
    Am J Respir Crit Care Med. 2020 Jan 10. doi: 10.1164/rccm.201911-2149.
    PubMed    


  16. VERRALL AJ, Chaidir L, Ruesen C, Apriani L, et al
    Lower BCG Protection Against Mycobacterium tuberculosis Infection After Exposure to Beijing Strains.
    Am J Respir Crit Care Med. 2020 Jan 8. doi: 10.1164/rccm.201912-2349.
    PubMed    


  17. NICHOLS DP, Moss RB
    Early Aspergillosis in Cystic Fibrosis and Air Trapping: Guilt by Association?
    Am J Respir Crit Care Med. 2020 Jan 6. doi: 10.1164/rccm.201912-2309.
    PubMed    


  18. MCSHANE H
    Controlled Human Infection Models - Is it Really Feasible to Give People Tuberculosis?
    Am J Respir Crit Care Med. 2020 Jan 6. doi: 10.1164/rccm.201912-2408.
    PubMed    


    December 2019
  19. GUPTA RK, Lipman M, Jackson C, Sitch A, et al
    Quantitative Interferon Gamma Release Assay and Tuberculin Skin Test Results to Predict Incident Tuberculosis: A Prospective Cohort Study.
    Am J Respir Crit Care Med. 2019 Dec 11. doi: 10.1164/rccm.201905-0969.
    PubMed     Abstract available


  20. ABUBAKAR I, Cobelens FG, Rangaka MX
    The Risk of Falsely Declaring Non-Inferiority of Novel Latent Tuberculosis Treatment in Large Trials.
    Am J Respir Crit Care Med. 2019 Dec 9. doi: 10.1164/rccm.201911-2258.
    PubMed    


    November 2019
  21. NISHIZAWA S, Tobino K
    Asymptomatic Tuberculous Pleurisy Mimicking Mesothelioma.
    Am J Respir Crit Care Med. 2019 Nov 25. doi: 10.1164/rccm.201906-1223.
    PubMed    


  22. BREUER O, Schultz A, Garratt LW, Turkovic L, et al
    Aspergillus Infections and Progression of Structural Lung Disease in Children with Cystic Fibrosis.
    Am J Respir Crit Care Med. 2019 Nov 20. doi: 10.1164/rccm.201908-1585.
    PubMed     Abstract available


  23. NAHID P, Mase SR, Migliori GB, Sotgiu G, et al
    Treatment of Drug-Resistant Tuberculosis. An Official ATS/CDC/ERS/IDSA Clinical Practice Guideline.
    Am J Respir Crit Care Med. 2019;200:e93-e142.
    PubMed     Abstract available


  24. STOUT JE, Turner NA, Belknap RW, Horsburgh CR, et al
    Optimizing the Design of Latent Tuberculosis Treatment Trials: Insights from Mathematical Modeling.
    Am J Respir Crit Care Med. 2019 Nov 11. doi: 10.1164/rccm.201908-1606.
    PubMed     Abstract available


  25. NARITA M, Sullivan Meissner J, Burzynski J
    Use of Modeling to Inform Tuberculosis Elimination Strategies.
    Am J Respir Crit Care Med. 2019 Nov 7. doi: 10.1164/rccm.201910-2061.
    PubMed    


    October 2019
  26. BROWN JS
    Improving Pulmonary Immunity to Bacterial Pathogens Through Streptococcus pneumoniae Colonisation of the Nasopharynx.
    Am J Respir Crit Care Med. 2019 Oct 30. doi: 10.1164/rccm.201910-2047.
    PubMed    


  27. TEZERA LB, Mansour S, Elkington P
    Reconsidering the Optimal Immune Response to Mycobacterium tuberculosis.
    Am J Respir Crit Care Med. 2019 Oct 28. doi: 10.1164/rccm.201908-1506.
    PubMed     Abstract available


  28. FOREMAN TW, Bucsan AN, Mehra S, Peloquin C, et al
    Isoniazid and Rifapentine Treatment Eradicates Persistent Mycobacterium tuberculosis in Macaques.
    Am J Respir Crit Care Med. 2019 Oct 24. doi: 10.1164/rccm.201903-0646.
    PubMed     Abstract available


  29. MENZIES NA, Parriott A, Shrestha S, Dowdy DW, et al
    Comparative Modelling of Tuberculosis Epidemiology and Policy Outcomes in California.
    Am J Respir Crit Care Med. 2019 Oct 18. doi: 10.1164/rccm.201907-1289.
    PubMed     Abstract available


    September 2019
  30. SURETTE MG, Bowdish DME
    Loss of Microbial Topography Precedes Infection in Infants.
    Am J Respir Crit Care Med. 2019;200:660-662.
    PubMed    


  31. SAGAR AS, Dodge DL, Salahuddin M, Warner MT, et al
    Pleural Diseases: Pleurodesis via Indwelling Pleural Catheter, Dasatinib-induced Pleural Effusion, and IL-27 in Tuberculosis Pleural Effusion.
    Am J Respir Crit Care Med. 2019;200:771-773.
    PubMed    


  32. KOTTHOFF-BURRELL E
    Candidemia (Blood Infection) and Other Candida Infections.
    Am J Respir Crit Care Med. 2019;200:P9-P10.
    PubMed    


    August 2019
  33. ORTON CM, Garner JL, Desai SR, Kemp SV, et al
    Aspergillus Cavitation Complicating Endobronchial Lung Volume Reduction Coil Placement.
    Am J Respir Crit Care Med. 2019 Aug 30. doi: 10.1164/rccm.201906-1176.
    PubMed    


  34. SCHAAF HS, Marais BJ
    The Role of Xpert MTB/RIF Ultra in Diagnosing Pulmonary Tuberculosis in Children.
    Am J Respir Crit Care Med. 2019 Aug 6. doi: 10.1164/rccm.201907-1492.
    PubMed    


  35. ZAR HJ, Workman LJ, Prins M, Bateman LJ, et al
    Tuberculosis Diagnosis in Children Using Xpert Ultra on Different Respiratory Specimens.
    Am J Respir Crit Care Med. 2019 Aug 5. doi: 10.1164/rccm.201904-0772.
    PubMed     Abstract available


  36. PARIKH R, Belok SH, Swamy L, Reardon CC, et al
    Adjunctive Therapies in the Management of Septic Shock.
    Am J Respir Crit Care Med. 2019;200:381-383.
    PubMed    


    July 2019
  37. PRAZAK J, Iten M, Cameron DR, Save J, et al
    Bacteriophages Improve Outcome in Experimental Staphylococcus Aureus Ventilator Associated Pneumonia.
    Am J Respir Crit Care Med. 2019 Jul 1. doi: 10.1164/rccm.201812-2372.
    PubMed     Abstract available


    June 2019
  38. MEEGAN JE, Bastarache JA
    NET Gain for Sepsis Research: New Approach to Assess Neutrophil Function in Patients.
    Am J Respir Crit Care Med. 2019 Jun 11. doi: 10.1164/rccm.201905-1074.
    PubMed    


    May 2019
  39. SEMLER MW, Singer M
    Deconstructing Hyperlactatemia in Sepsis Using ScvO2 and Base Deficit.
    Am J Respir Crit Care Med. 2019 May 19. doi: 10.1164/rccm.201904-0899.
    PubMed    


  40. GAUTAM S, Sharma L, Dela Cruz CS
    Teaching an Old Intensivist Neutrophil Tricks: Using Alveolar Neutrophilia to Diagnose Ventilator-associated Pneumonia.
    Am J Respir Crit Care Med. 2019;199:1178-1181.
    PubMed    


  41. SANDERS DB, Nichols DP
    Developmental Milestones in Pediatric Research: A Case for Including Efficacy as Part of Interventional Trials in Infants with Cystic Fibrosis.
    Am J Respir Crit Care Med. 2019;199:1181-1182.
    PubMed    


  42. NIEDERMAN MS, Nair GB, Matt U, Herold S, et al
    Update in Lung Infections and Tuberculosis 2018.
    Am J Respir Crit Care Med. 2019 May 1. doi: 10.1164/rccm.201903-0606.
    PubMed    


  43. VAN DE GROEP K, Verboom DM, van de Veerdonk FL, Haas PA, et al
    Detection of Invasive Aspergillosis in Critically Ill Patients with Influenza: the Role of Plasma Galactomannan.
    Am J Respir Crit Care Med. 2019 May 1. doi: 10.1164/rccm.201903-0587.
    PubMed    


  44. RUSSELL JA, Gordon AC, Walley KR
    Early May Be Better: Early Low-Dose Norepinephrine in Septic Shock.
    Am J Respir Crit Care Med. 2019;199:1049-1051.
    PubMed    


    April 2019
  45. KRANZER K, Kalsdorf B, Heyckendorf J, Andres S, et al
    New WHO Treatment Recommendations for Multidrug-Resistant Tuberculosis: Are We Well Enough Prepared?
    Am J Respir Crit Care Med. 2019 Apr 26. doi: 10.1164/rccm.201902-0260.
    PubMed    


  46. GUPTA E, Jacobs MD, George G, Roman J, et al
    Beyond the ICU: Frailty and Post-ICU Disability. Healthcare Use after Acute Respiratory Distress Syndrome and Severe Sepsis.
    Am J Respir Crit Care Med. 2019;199:1028-1030.
    PubMed    


    March 2019
  47. PRESCOTT HC
    Identifying Sepsis Subtypes from Routine Clinical Data.
    Am J Respir Crit Care Med. 2019 Mar 8. doi: 10.1164/rccm.201903-0532.
    PubMed    


    January 2019
  48. DHEDA K, Lenders L, Srivastava S, Magombedze G, et al
    Spatial Network Mapping of Pulmonary Multidrug-Resistant Tuberculosis Cavities Using RNA Sequencing.
    Am J Respir Crit Care Med. 2019 Jan 29. doi: 10.1164/rccm.201807-1361.
    PubMed     Abstract available


  49. TE BRAKE LHM, Boeree MJ, Aarnoutse RE
    Conflicting Findings on an Intermediate Dose of Rifampicin for Pulmonary Tuberculosis.
    Am J Respir Crit Care Med. 2019 Jan 15. doi: 10.1164/rccm.201811-2101.
    PubMed    


  50. VELASQUEZ GE, Brooks MB, Coit JM, Sanchez Garavito E, et al
    Reply to: Conflicting Findings on an Intermediate Dose of Rifampicin for Pulmonary Tuberculosis.
    Am J Respir Crit Care Med. 2019 Jan 15. doi: 10.1164/rccm.201812-2281.
    PubMed    


  51. HANSEN C, Scupp T, Nelson J, Brainard J, et al
    Implications of Procalcitonin Testing in Critically Ill Patients with Sepsis.
    Am J Respir Crit Care Med. 2019;199:232-234.
    PubMed    


    December 2018
  52. SCICLUNA BP, Baillie JK
    The Search for Efficacious New Therapies in Sepsis Needs to Embrace Heterogeneity.
    Am J Respir Crit Care Med. 2018 Dec 12. doi: 10.1164/rccm.201811-2148.
    PubMed    


    November 2018
  53. CONSONNI F, Nacoti M, Amini M, Vedovati S, et al
    Severe Necrotizing Staphylococcal Pneumonia with Late Life-Threatening Tracheo-Bronchial Involvement in Infant.
    Am J Respir Crit Care Med. 2018 Nov 15. doi: 10.1164/rccm.201803-0507.
    PubMed    


  54. JONES TK, Wong HR, Meyer NJ
    HDL Cholesterol: A "Pathogen Lipid Sink" for Sepsis?
    Am J Respir Crit Care Med. 2018 Nov 14. doi: 10.1164/rccm.201811-2084.
    PubMed    


    October 2018
  55. SCHLUGER NW
    Tuberculosis Elimination, Research, and Respect for Persons.
    Am J Respir Crit Care Med. 2018 Oct 19. doi: 10.1164/rccm.201809-1623.
    PubMed    


  56. KESHAVJEE S, Amanullah F, Cattamanchi A, Chaisson R, et al
    Moving Toward Tuberculosis Elimination: Critical Issues for Research in Diagnostics and Therapeutics for Tuberculosis Infection.
    Am J Respir Crit Care Med. 2018 Oct 18. doi: 10.1164/rccm.201806-1053.
    PubMed     Abstract available


  57. MARTINEZ L, Andrews JR
    Improving Tuberculosis Case Finding in Persons Living with Advanced HIV through New Diagnostic Algorithms.
    Am J Respir Crit Care Med. 2018 Oct 1. doi: 10.1164/rccm.201809-1702.
    PubMed    


    September 2018
  58. YOON C, Semitala FC, Asege L, Katende J, et al
    Yield and Efficiency of Novel Intensified Tuberculosis Case-Finding Algorithms for People Living with HIV.
    Am J Respir Crit Care Med. 2018 Sep 7. doi: 10.1164/rccm.201803-0490.
    PubMed     Abstract available


    August 2018
  59. ELKINGTON PT, Bateman AC, Thomas GJ, Ottensmeier CH, et al
    Implications of Tuberculosis Reactivation after Immune Checkpoint Inhibition.
    Am J Respir Crit Care Med. 2018 Aug 24. doi: 10.1164/rccm.201807-1250.
    PubMed    


    June 2018
  60. VELASQUEZ GE, Brooks MB, Coit JM, Pertinez H, et al
    Efficacy and Safety of High-Dose Rifampin in Pulmonary Tuberculosis: A Randomized Controlled Trial.
    Am J Respir Crit Care Med. 2018 Jun 29. doi: 10.1164/rccm.201712-2524.
    PubMed     Abstract available


  61. DHEDA K, Lenders L, Magombedze G, Srivastava S, et al
    Drug Penetration Gradients Associated with Acquired Drug Resistance in Tuberculosis Patients.
    Am J Respir Crit Care Med. 2018 Jun 7. doi: 10.1164/rccm.201711-2333.
    PubMed     Abstract available


    May 2018
  62. LAN F, Zhang N, Holtappels G, Ruyck N, et al
    Staphylococcus aureus Induces Mucosal Type 2 Immune Response via Epithelial Cell Derived Cytokines.
    Am J Respir Crit Care Med. 2018 May 16. doi: 10.1164/rccm.201710-2112.
    PubMed     Abstract available


    April 2018
  63. MONEDERO-RECUERO I
    Drug-resistant Tuberculosis in Europe. What are We Waiting for?
    Am J Respir Crit Care Med. 2018 Apr 18. doi: 10.1164/rccm.201803-0497.
    PubMed    


  64. SULIMAN S, Thompson E, Sutherland J, Weiner Rd J, et al
    Four-gene Pan-African Blood Signature Predicts Progression to Tuberculosis.
    Am J Respir Crit Care Med. 2018 Apr 6. doi: 10.1164/rccm.201711-2340.
    PubMed     Abstract available


    March 2018
  65. ABUBAKAR I, Gupta RK, Rangaka MX, Lipman M, et al
    Update in Tuberculosis and Non-tuberculous Mycobacteria 2017.
    Am J Respir Crit Care Med. 2018 Mar 14. doi: 10.1164/rccm.201801-0106.
    PubMed    


  66. COX D, Keane J
    Platelets and Tuberculosis: Small Cells, Not So Innocent Bystanders.
    Am J Respir Crit Care Med. 2018 Mar 6. doi: 10.1164/rccm.201802-0279.
    PubMed    


  67. GUNTHER G, van Leth F, Alexandru S, Altet N, et al
    Clinical Management of Multidrug-resistant Tuberculosis in 16 European Countries.
    Am J Respir Crit Care Med. 2018 Mar 6. doi: 10.1164/rccm.201710-2141.
    PubMed     Abstract available


    February 2018
  68. SCHWANDER S, Keane J
    Cause or Effect - the Elusive Role of Regulatory T Cells in Tuberculosis.
    Am J Respir Crit Care Med. 2018 Feb 28. doi: 10.1164/rccm.201802-0233.
    PubMed    


  69. FOX KA, Kirwan DE, Whittington AM, Krishnan N, et al
    Platelets Regulate Pulmonary Inflammation and Tissue Destruction in Tuberculosis.
    Am J Respir Crit Care Med. 2018 Feb 8. doi: 10.1164/rccm.201710-2102.
    PubMed     Abstract available


    December 2017
  70. ERNST JD
    Float Like Bacilli, STING Like a B: Type I Interferons in Tuberculosis.
    Am J Respir Crit Care Med. 2017 Dec 20. doi: 10.1164/rccm.201712-2368.
    PubMed    



  71. What Is Sepsis?
    Am J Respir Crit Care Med. 2017;196:P21-P22.
    PubMed    


    November 2017
  72. BENARD A, Sakwa I, Schierloh P, Colom A, et al
    B Cells Producing Type I Interferon Modulate Macrophage Polarization in Tuberculosis.
    Am J Respir Crit Care Med. 2017 Nov 21. doi: 10.1164/rccm.201707-1475.
    PubMed     Abstract available


    October 2017
  73. DIVANGAHI M, Behr MA
    Cracking the Vaccine Code in Tuberculosis.
    Am J Respir Crit Care Med. 2017 Oct 18. doi: 10.1164/rccm.201707-1489.
    PubMed     Abstract available


  74. MARTINEZ L, Handel A, Shen Y, Chakraburty S, et al
    A Prospective Validation of a Clinical Algorithm to Detect Tuberculosis in Child Contacts.
    Am J Respir Crit Care Med. 2017 Oct 16. doi: 10.1164/rccm.201706-1210.
    PubMed    


Thank you for your interest in scientific medicine.


AMEDEO Bacterial Infections and Mycoses is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: